News und Analysen

As of mid-May 2025, the S&P 500 has turned positive year-to-date (YTD) for the first time in many weeks. Stocks across multiple sectors have broadly recovered from the jolt of tariff news and

Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the

Investors searching for high-quality opportunities in the pharmaceutical space should keep a close eye on stocks trading at extremely oversold levels. One of the most popular ways to measure this

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector.

Biotech stocks lagged the broader market

It has been a turbulent start to the year for the healthcare industry, as concerns about major cuts to Medicare and Medicaid coincide with the impact of tariffs on supplies and many other

DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) market, delivering outstanding first-quarter 2025 financial results that

While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and

Insiders are buying stock in 2025, and activity is not limited to a single sector or market cap. This article looks at the top three insider buys from April based on market cap and the number of

In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially

Down about 8% in the last month, quantum computing firm D-Wave Quantum Inc. (NYSE: QBTS) is a leader in an industry hit hard by the escalating trade war between the United States and China. While

Among the companies that have reported earnings so far in the Q1 2025 cycle, Pegasystems (NASDAQ: PEGA) is one that stands out. The AI stock popped by nearly 29% after its earnings release.

The

If you have been or are thinking about getting into AbbVie (NYSE: ABBV), there is still time to do so. The AbbVie stock price is in a sustained uptrend

Viking Therapeutics Inc. (NASDAQ: VKTX) reported earnings after the market closed on Apr. 23. The stock is pushing higher as investors attempt to sort

There’s a new commodity in the financial markets today, and that’s any stock (or business, for that matter) that carries a certain level of immunity to the recent trade tariffs rolled out by

The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), is back in the green in 2025 as of the Apr. 21 close. Shares were down